Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

http://www.wikidata.org/entity/Q41561760

about

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems Dendritic cells and immunotherapy for malignant disease.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cells.Immunomodulatory gene therapy for haematological malignancies.T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back.Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.

P2860

Q24604091-3D6160D8-91B3-4C10-884D-AF9FF896DEB1 Q33928557-2E79EEAE-FA98-44E3-96C8-F29A646168F4 Q34216506-3298713B-B2AC-4E57-9C2D-A9E2C08478A4 Q34279672-FA01F1CE-52EE-4C36-A9E8-09F56AE2BC63 Q34293490-3F2F56F9-837B-449F-83F4-5C7FFD6C3411 Q34579664-6E8B21F9-DD31-4C6B-96AF-52DB8D156459 Q36287359-4F64F211-91E2-4C8D-A857-F9FE1CE97A36 Q37384050-66F6A646-F991-4C16-8555-460F19085A92 Q40572007-327D66A9-99D3-468C-B3B2-5B966DFEB5AB Q44117304-1FCCBD5A-053D-4CF0-BFE8-BF11DDCD2C20 Q44632359-3467AFF5-76C7-4637-8CE1-C0E2459F1BCE

P2860

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

http://www.wikidata.org/entity/Q41561760

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

@en

type

label

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

@en

prefLabel

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

@en

P1433

Q41561760-73A42D27-FD60-4CAA-A60A-EFA1A30938B4

P1476

Q41561760-74E6BDC6-F17B-462E-8583-E7366EE06C61

P2093

Q41561760-2F95A0DF-4C28-49AF-9248-82D08DF3F487

Q41561760-32D09FE9-F4B5-4ACE-AB5E-666BB398431B

Q41561760-852EF067-E979-403A-B845-1CDCA8275E7D

P2860

Q41561760-0DEB990D-C2A2-487C-8F71-C6D13441EA74

Q41561760-10D97566-3744-4421-A262-482A8200E166

Q41561760-3B1DC130-CD75-47EE-8E63-587EF7DA7A14

Q41561760-4CE5BA1E-50D2-450C-B7FB-A46D9769E458

Q41561760-61FCF6AC-8692-4D3D-B0E3-008931191A25

Q41561760-9D421B8D-5DFB-447D-B588-956FFE1CF2D1

Q41561760-CEBA1E7D-60B6-466A-BB46-6C677BDFAE84

Q41561760-E836DB03-3812-4111-87CE-BD06FD164EB4

Q41561760-F289DC91-A4D0-4582-A268-63D7F44965DB

P304

Q41561760-EA733778-CA28-44DB-A94E-A00F3867F61D

P31

Q41561760-8A0B33B8-F569-4B49-BD5E-21B91162D11D

P356

Q41561760-4351889F-E6B4-4B29-B23A-D0391B348685

P478

Q41561760-2D07E023-B7B6-438A-8655-8BC8392D7126

P577

Q41561760-8C309FBC-4FF3-4807-A47D-DC672B0248A2

P698

Q41561760-193C871A-7E3A-4A85-A0F1-FD9C086B16AC

P921

Q41561760-945001BD-D9F4-4F68-8557-F50D6F141E8B

P356

J.1600-065X.1997.TB00985.X

P1433

Immunological Reviews

P1476

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.

@en

P2093

Falkenburg JH

http://www.w3.org/2001/XMLSchema#string

Smit WM

http://www.w3.org/2001/XMLSchema#string

Willemze R

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells

Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance.

Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

Identical-twin bone marrow transplants for leukemia.

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

P304

223-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-065X.1997.TB00985.X

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9255633

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia